MedPath

Study to Identify the Reduction of Exacerbations Resulting in Hospital Admission in Patients With COPD.

Completed
Conditions
COPD Exacerbation
Interventions
Diagnostic Test: Breath Detect Platform
Registration Number
NCT05440188
Lead Sponsor
Universidad Autonoma de Madrid
Brief Summary

identification of the reduction of exacerbations resulting in hospital admission in COPD patients after the use of the Breath Detect telemedicine platform.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
80
Inclusion Criteria
  • COPD diagnosed in GOLD II state or higher
Exclusion Criteria
  • Can´t read and talk in spanish

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
COPDBreath Detect PlatformPatients over 65 years old diagnosed with COPD in GOLD II state or higher who uses Breath Detect Platform for monitoring their respiratory health status.
Primary Outcome Measures
NameTimeMethod
Number of hospital admissions due to exacerbations24 weeks
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

CS Entrevías

🇪🇸

Madrid, Spain

© Copyright 2025. All Rights Reserved by MedPath